Delivery Order SPE2DR25D1100-SPE2DR26FCN3B
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on June 30, 2025, for the supply of Infuvite Pediatric Vial 5ML, a pediatric intravenous nutritional supplement. This firm fixed-price delivery order, valued at $31,264.79, represents a non-set-aside competitive award and is set for ultimate completion by July 1, 2025. The product will be delivered to the company's location in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate...
- The Defense Logistics Agency awarded a delivery order valued at $4,103.51 to AmerisourceBergen Drug Corp for Infuvite Pediatric Vial 5ML, a pediatric nutritional supplement product. The contract is a firm fixed-price delivery order with an ultimate completion date of September 5, 2025, and was competitively awarded without set-aside designation. The place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $32,031.97 to AmerisourceBergen Drug Corp for the supply of Infuvite Adult Bulk Vial 100ML, with an ultimate completion date of June 3, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at AmerisourceBergen's Conshohocken, Pennsylvania location. The award represents a continuation of the company's role as a critical pharmaceutical supplier to federal...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,944.39 to AmerisourceBergen Drug Corp on November 5, 2025, for the supply of Infuvite Adult Vial 10ML, a parenteral nutrition product used in medical settings. This competitively awarded, firm fixed-price contract represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), which is valued at $999,999,999.00 and extends through December 2026. The...
- The Defense Logistics Agency awarded a delivery order valued at $15,733.52 to AmerisourceBergen Drug Corp for the supply of Infuvite Pediatric Vial 5ML, with a completion date of October 27, 2025. This competitively awarded, firm fixed-price delivery order represents a non-set-aside contract that will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The award falls under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 17, 2025, for the supply of Infuvite Pediatric Bulk Vial 50ml pharmaceutical product. This firm fixed-price delivery order, valued at $5,017.61, represents a non-set-aside competitive award with an ultimate completion date of September 18, 2025. The contract will be performed at AmerisourceBergen's Corporate Office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, received a $5,068.51 firm fixed price delivery order from the Defense Logistics Agency (DLA) for Infuvite Adult Vial 10ml on November 3, 2025, with an ultimate completion date of November 4, 2025. This non-set-aside award represents a child contract under AmerisourceBergen's significant Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 2, 2025, for the supply of Infuvite Pediatric Bulk Vial 50ML, a pediatric parenteral nutrition product. The delivery order, valued at $3,244.45, utilizes firm fixed-price pricing and represents a non-set-aside competitive award. The place of performance is AmerisourceBergen's facility in Conshohocken, Pennsylvania, with an ultimate completion date of September 3, 2025. This delivery order is...
- AmerisourceBergen Drug Corp was awarded a delivery order valued at $5,214.08 for Infuvite Adult 10ML (5 units) by the Defense Logistics Agency's Medical Supply Chain on August 14, 2025, with an ultimate completion date of August 15, 2025. The contract employs firm fixed-price pricing and was competitively awarded with no set-aside designation. Performance will occur at the vendor's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child contract under...
- The Defense Logistics Agency awarded a delivery order valued at $13,460.20 to AmerisourceBergen Drug Corp for Infuvite Adult Bulk Vial 100ML, a pharmaceutical product. The award, issued on September 17, 2025, represents a firm fixed-price delivery order with an ultimate completion date of September 18, 2025. This non-set-aside contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order is a child contract falling under a larger...
- SPE2DR25D1100Indefinite Delivery Contract
- SPE2DR25D1100-SPE2DR26FCN3BDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $33,220.58 to AmerisourceBergen Drug Corp for Infuvite Pediatric Vial 5ML on November 7, 2025, with an ultimate completion date of November 10, 2025. This firm fixed-price delivery order is non-competitive and carries no set-aside designation. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical distributor and medical supply provider to federal healthcare systems, particularly supporting military and veteran medical needs. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, valued at $999,999,999.00 and extending through December 2026. The parent IDC functions as a comprehensive global pharmaceutical support vehicle enabling the company to supply a broad range of pharmaceutical products, medications, vaccines, and medical supplies to military healthcare programs worldwide. AmerisourceBergen's contract portfolio demonstrates consistent competitively awarded agreements with the Defense Logistics Agency, reflecting the company's capability to meet federal medical procurement requirements across multiple therapeutic domains and product categories.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $33.2k | 11/7/25 |